Showing results (11-20 of 4,202) with videos related to
Sort By:
Pageof 421
Neuroscience and Biobehavioral Reviews|November 11, 1998
Possible role(s) of neurokinins in CNS development and neurodegenerative or other disordersR B RaffaPeptides|March 1, 1989
Supraspinal FMRFamide antagonizes morphine-induced horizontal, but not vertical, locomotor activityR B RaffaLife Sciences|May 19, 1998
Screen of receptor and uptake-site activity of hypericin component of St. John's wort reveals sigma receptor bindingR B RaffaJournal of Clinical Pharmacy and Therapeutics|May 7, 2011
A proposed mechanism for chemotherapy-related cognitive impairment ('chemo-fog')R B RaffaJournal of Clinical Pharmacy and Therapeutics|May 10, 2013
Cancer 'survivor-care': II. Disruption of prefrontal brain activation top-down control of working memory capacity as possible mechanism for chemo-fog/brain (chemotherapy-associated cognitive impairment)R B RaffaJournal of Clinical Pharmacy and Therapeutics|February 24, 2010
The M5 muscarinic receptor as possible target for treatment of drug abuseR B RaffaNeuroscience Letters|June 30, 1986
Evidence for a role of conditioning in the development of tolerance to morphine-induced inhibition of gastrointestinal transit in ratsR B Raffa, F PorrecaLife Sciences|January 1, 1989
Thermodynamic analysis of the drug-receptor interactionR B Raffa, F PorrecaJournal of Clinical Pharmacy and Therapeutics|April 20, 2011
Multi-mechanistic analgesia for opioid-induced hyperalgesiaR B Raffa, J V PergolizziNIDA Research Monograph|January 1, 1991
[D-Met2]-FMRFamide (DMFa): production of naloxone-sensitive antinociception in mouse tail-flick testR B Raffa, C D ConnellyPageof 421